The results from our Phase 2a clinical trial have shown that bexarotene is capable of regenerating lost myelin – the protective coating that surrounds nerve fibres, which is damaged in MS. Now, a new trial of the diabetes drug metformin will build on this work.
A group of leading neurologists in childhood MS have agreed that children with multiple sclerosis are not a high risk group for coronavirus. And that almost all children should return to school full time.
Women with MS often report fewer symptoms during pregnancy. But studies exploring whether becoming pregnant or having children affects whether or when someone develops MS have so far been inconclusive. Now, the biggest study yet suggests pregnancy may be linked to a delay in experiencing one of the early signs of MS.
Findings from a UK survey show that during the early phase of the pandemic, when strict lockdown measures were taken, people with MS had a similar chance of getting coronavirus to the general population. The data reinforces that self-isolating greatly decreased the risk of coronavirus.
A committee in the House of Lords is investigating some of the long term impacts of the COVID-19 pandemic. It wants to hear from a wide range of people before making recommendations to the UK government.